Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Case Report
Authors: D’Antonio, Antonioa; * | Addesso, Mariab | Memoli, Domenicoa | Cascone, Annamariaa | Cremone, Luigic
Affiliations: [a] Department of Pathologic Anatomy A.O.U. S. Giovanni di Dio e Ruggi D’Aragona, Salerno, Italy | [b] Unit of Pathologic Anatomy, ASL Salerno, Hospital Tortora, Pagani (SA), Italy | [c] Breast Unit, Salerno, Italy, A.O.U. San Giovanni di Dio e Ruggi D’Aragona, Salerno, Italy
Correspondence: [*] Corresponding author: Antonio D’ Antonio, Unit of Pathologic Anatomy, A.O. “San Giovanni di Dio e Ruggi d’Aragona” via S. Leonardo, Salerno, Italy. Tel.: 0039 089672366; Fax: 0039 089672739; E-mail: ada66@inwind.it
Abstract: Neuroendocrine features are detectable in carcinomas of the breast either as scattered cells, that are recognized by their expression of neuroendocrine cell markers. Instead, pure breast carcinomas with neuroendocrine features (NEBC) are very rare and represent <1% of all breast cancer. Usually NEBC may be well or poorly differentiated and more frequent in older woman. These tumors showed variable histological pattern but a common feature is represented by expression of neuroendocrine markers. Here we report a case of a primary multicentric low-grade neuroendocrine carcinoma of the breast presented because of its rarity and for the unusual tubular and cribriform pattern resembling a well-differentiated conventional breast carcinoma. The tumor was treated with left quadrantectomy with concomitant wide excisional biopsy of other two nodules and lymph node sentinel biopsy. No recurrence was observed during 1-year follow-up. Because of its rarity and variability of morphologic features, there exist diagnostic challenges for pathologists to differentiate primary NEBC to some conventional breast carcinomas and to the breast metastasis from neuroendocrine tumor of the lung or gastrointestinal tract. It is important to be able recognize this tumor in order to avoid potential misdiagnosis and improper management of afflicted patients.
Keywords: Neuroendocrine tumor, breast, differential diagnosis, immunohistochemistry
DOI: 10.3233/BD-160226
Journal: Breast Disease, vol. 36, no. 4, pp. 161-164, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl